View Older Stories View More Recent Stories

Mar 31, 2025 04:57PM Form SCHEDULE 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 31, 2025 04:54PM Form SCHEDULE 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 25, 2025 04:30PM T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting

Mar 24, 2025 09:01AM Surrozen (SRZN) Announces Oversubscribed $175M Private Placement

Mar 24, 2025 09:00AM Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases   

Mar 20, 2025 04:05PM Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update

Mar 17, 2025 07:58PM Form SCHEDULE 13D/A Mineralys Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 17, 2025 08:00AM Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine

Mar 17, 2025 08:00AM Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine

Mar 12, 2025 06:00AM Vivace Therapeutics Raises $35 Million in Series D Financing to Support Clinical Development of First-in-Class Cancer Drug Targeting the Hippo Pathway

Mar 10, 2025 04:33PM Form SCHEDULE 13D/A Janux Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 6, 2025 04:35PM Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025 08:17PM Form SCHEDULE 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 3, 2025 09:00AM Be Biopharma Announces Appointment of Susan Abu-Absi, Ph.D. as Chief Operating Officer

Feb 21, 2025 04:15PM Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 21, 2025 06:12AM Weekly Roundup: 12 Finance Press Releases You Need to See

Feb 20, 2025 08:00AM T-knife Therapeutics Welcomes Dr. Sophie Papa to its Board of Directors

Feb 18, 2025 04:25PM Form SCHEDULE 13D Sionna Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 18, 2025 07:01AM Solid Biosciences (SLDB) Prices 35.74M Share Offering at $4.03/sh

Feb 18, 2025 07:00AM Solid Biosciences Announces Pricing of Underwritten Offering

Feb 14, 2025 06:44PM Form SCHEDULE 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:43PM Form SCHEDULE 13G/A Tenaya Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:43PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:42PM Form SCHEDULE 13G/A NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:41PM Form SCHEDULE 13G/A Protara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:41PM Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:40PM Form SCHEDULE 13G/A MACROGENICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:39PM Form SCHEDULE 13G/A GLYCOMIMETICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:39PM Form SCHEDULE 13G/A Longboard Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:38PM Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:36PM Form SCHEDULE 13G/A Evolent Health, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:34PM Form SCHEDULE 13G/A Ensysce Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:33PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:32PM Form SCHEDULE 13G/A Day One Biopharmaceutica Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:31PM Form SCHEDULE 13G/A Adagio Medical Holdings, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:30PM Form SCHEDULE 13G/A Cytek Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:30PM Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:29PM Form SCHEDULE 13G/A CYBIN INC. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:28PM Form SCHEDULE 13G/A BioAge Labs, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:28PM Form SCHEDULE 13G/A CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:27PM Form SCHEDULE 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:26PM Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:26PM Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 06:25PM Form SCHEDULE 13G/A Zura Bio Ltd Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2025 04:30PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31

Feb 14, 2025 08:56AM Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

Feb 12, 2025 08:00AM T-knife Therapeutics to Participate in Two Investor Conferences in March 

Feb 12, 2025 07:00AM Abcuro Announces $200 Million Series C Financing to Advance Its First-In-Class Medicine in Development for Inclusion Body Myositis

Feb 6, 2025 09:00AM Be Biopharma Announces Publication of Manuscript in the Molecular Therapy Journal Demonstrating In Vivo Engraftment and Tracking of Ex-vivo-Generated Plasma Cells in Non-Human Primates

Feb 3, 2025 05:39PM Form SCHEDULE 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

View More Recent Stories View Older Stories